112 related articles for article (PubMed ID: 12821338)
1. CA125 and UQCRFS1 FISH studies of ovarian carcinoma.
Kaneko SJ; Gerasimova T; Smith ST; Lloyd KO; Suzumori K; Young SR
Gynecol Oncol; 2003 Jul; 90(1):29-36. PubMed ID: 12821338
[TBL] [Abstract][Full Text] [Related]
2. Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples.
Ohashi Y; Kaneko SJ; Cupples TE; Young SR
Gynecol Oncol; 2004 Apr; 93(1):54-8. PubMed ID: 15047214
[TBL] [Abstract][Full Text] [Related]
3. Structure, sequence and location of the UQCRFS1 gene for the human Rieske Fe-S protein.
Pennacchio LA; Bergmann A; Fukushima A; Okubo K; Salemi A; Lennon GG
Gene; 1995 Apr; 155(2):207-11. PubMed ID: 7721092
[TBL] [Abstract][Full Text] [Related]
4. Assignment of the gene (UQCRFS1) for the Rieske iron-sulfur protein subunit of the mitochondrial cytochrome bc1 complex to the 22q13 and 19q12-q13.1 regions of the human genome.
Duncan AM; Anderson L; Duff C; Ozawa T; Suzuki H; Worton R; Rozen R
Genomics; 1994 May; 21(1):281-3. PubMed ID: 8088805
[No Abstract] [Full Text] [Related]
5. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
Fawzy A; Mohamed MR; Ali MA; Abd El-Magied MH; Helal AM
Asian Pac J Cancer Prev; 2016; 17(1):323-33. PubMed ID: 26838232
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Yin BW; Dnistrian A; Lloyd KO
Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
[TBL] [Abstract][Full Text] [Related]
7. Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
Ellinger J; Gromes A; Poss M; Brüggemann M; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Oncotarget; 2016 Dec; 7(52):86490-86499. PubMed ID: 27845902
[TBL] [Abstract][Full Text] [Related]
8. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.
Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R
Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.
Yin BW; Lloyd KO
J Biol Chem; 2001 Jul; 276(29):27371-5. PubMed ID: 11369781
[TBL] [Abstract][Full Text] [Related]
10. An amplified comparative fluorescence resonance energy transfer immunosensing of CA125 tumor marker and ovarian cancer cells using green and economic carbon dots for bio-applications in labeling, imaging and sensing.
Hamd-Ghadareh S; Salimi A; Fathi F; Bahrami S
Biosens Bioelectron; 2017 Oct; 96():308-316. PubMed ID: 28525848
[TBL] [Abstract][Full Text] [Related]
11. TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex III.
Bottani E; Cerutti R; Harbour ME; Ravaglia S; Dogan SA; Giordano C; Fearnley IM; D'Amati G; Viscomi C; Fernandez-Vizarra E; Zeviani M
Mol Cell; 2017 Jul; 67(1):96-105.e4. PubMed ID: 28673544
[TBL] [Abstract][Full Text] [Related]
12. Bi-Allelic UQCRFS1 Variants Are Associated with Mitochondrial Complex III Deficiency, Cardiomyopathy, and Alopecia Totalis.
Gusic M; Schottmann G; Feichtinger RG; Du C; Scholz C; Wagner M; Mayr JA; Lee CY; Yépez VA; Lorenz N; Morales-Gonzalez S; Panneman DM; Rötig A; Rodenburg RJT; Wortmann SB; Prokisch H; Schuelke M
Am J Hum Genet; 2020 Jan; 106(1):102-111. PubMed ID: 31883641
[TBL] [Abstract][Full Text] [Related]
13. HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.
Liu D; Kong D; Li J; Gao L; Wu D; Liu Y; Yang W; Zhang L; Zhu J; Jin X
J Ovarian Res; 2018 Jun; 11(1):47. PubMed ID: 29903044
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
15. Serum CA125 level before the development of ovarian cancer.
Kobayashi H; Ooi H; Yamada Y; Sakata M; Kawaguchi R; Kanayama S; Sumimoto K; Terao T
Int J Gynaecol Obstet; 2007 Nov; 99(2):95-9. PubMed ID: 17643440
[TBL] [Abstract][Full Text] [Related]
16. Ovarian vein vs peripheral blood CA125 serum levels: a comparative study.
Podnos YD; Gamboa G; Kurosaki T; Buller R; Walker JL; Manetta A
Gynecol Oncol; 1997 Jul; 66(1):71-4. PubMed ID: 9234924
[TBL] [Abstract][Full Text] [Related]
17. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
18. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of elevated serum CA125 levels in patients with epithelial ovarian cancer.
Bouanène H; Harrabi I; Ferchichi S; Ben Limem H; Miled A
Bull Cancer; 2007 Jul; 94(7):E18-22. PubMed ID: 17723943
[TBL] [Abstract][Full Text] [Related]
20. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
Kadija S; Stefanovic A; Jeremic K; Radojevic MM; Nikolic L; Markovic I; Atanackovic J
Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
